One Pager as on August 31, 2024
Potential growth tailwinds in Indian Economy. | |
Opportunity to capitalize on Indian Entrepreneurship. | |
Opportunity to capture market / economic cycles. | |
Potential to create wealth and generate alpha over long-term. | |
Small caps are generally under-researched and under-owned and hence provides an opportunity for stock-picking at reasonable valuations. | |
Small Caps could be beneficiaries of structural reforms announced from time to time. | |
Small caps also provide exposure to companies which are potential market leaders in the industries they operate in (a few examples include textile, paper, sugar, luggage) and have potential to become midcaps of tomorrow as they achieve scale. |
Security | % to Net Assets |
Indus Towers Limited | 2.92% |
PCBL Limited | 2.92% |
Century Textiles & Industries Limited | 2.85% |
GAIL (India) Limited | 2.70% |
Anant Raj Limited | 2.42% |
CESC Limited | 2.32% |
Glenmark Pharmaceuticals Limited | 2.30% |
Granules India Limited | 2.18% |
Firstsource Solutions Limited | 2.13% |
Cholamandalam Financial Holdings Limited | 2.12% |
Total | 24.85% |
Sector | MMSCF | BSE 250 Small Cap TRI |
Capital Goods | 16.03% | 14.91% |
Financial Services | 9.38% | 18.28% |
Healthcare | 8.41% | 11.02% |
Fast Moving Consumer Goods | 5.77% | 4.21% |
Automobile And Auto Components | 4.92% | 5.40% |
*Mahindra Manulife Small Cap Fund
Data as on August 31, 2024
Fresh Additions | Complete Exits |
Security | Security |
Inox Green Energy Services Limited | - |
Premier Energies Limited | - |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant
portfolio changes during the month and should not be construed as recommendation to buy/sell/
hold. The fund manager may or may not choose to hold these companies/stocks, from time to
time. Investors are requested to consult their financial, tax and other advisors before taking any
investment decision(s). Data as on August 31, 2024
^Benchmark ^^Additional Benchmark. Inception/Allotment date: 12-Dec-22.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since
inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan
under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 12-Dec-22.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal
amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment
internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
The performance details provided above are of
Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Abhinav Khandelwal manages 6 schemes
and Mr. Manish Lodha manages 10 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on August 30, 2024
Note: As August 31, 2024 was a non - business day, the schemes returns disclosed are as on August 30,2024, except for Mahindra Manulife Liquid Fund and Mahindra Manulife Overnight
Fund which is as of August 31, 2024.
This product is suitable for investors who are seeking*:
• Long term capital appreciation;
• Investment predominantly in equity and equity related securities of small cap companies.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.